Your browser doesn't support javascript.
loading
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan.
Hara, Takuto; Matsushita, Yuto; Harada, Kenichi; Fujimoto, Naohiro; Fujisawa, Masato; Miyake, Hideaki.
Affiliation
  • Hara T; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Matsushita Y; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Harada K; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Fujimoto N; Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Fujisawa M; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Miyake H; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Int J Urol ; 31(6): 696-698, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38424707
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antibodies, Monoclonal Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antibodies, Monoclonal Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: